Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-90
SponsorFundacion Miguel Servet
About this trial
The main aims of this study are:
1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
Eligibility criteria
Qualifiers
All patients operated by the HPB Surgical Unit in the last 10 years (retrospective)
All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).
Disqualifiers
Patients not eligible for surgery
Patients not interested in taking part in the study
Trial design
Treatments tested in this trial
- Hepatobiliopancreatic surgery
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov